MetaCap

Claritev (CTEV) vs Repay (RPAY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Repay (RPAY) has outperformed Claritev (CTEV) over the past year, gaining 21.2% versus a loss of 61.2%. Over five years, RPAY leads with a -77.6% price change compared with -89.5% for CTEV. Repay is the larger company by market cap ($363.9 million vs $312.1 million), about 1.2 times the size, while Claritev is growing revenue faster (+3.7% vs -1.2%).

On valuation, Claritev trades at a lower forward P/E (2.4x vs 3.9x for Repay). Claritev converts more of its revenue into profit, with a net margin of -29.4% versus -83.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CTEV-61.21%RPAY+21.20%
+56%-11%-77%
Nov 21, 20251 yearNov 20, 2026
CTEV-87.02%RPAY-79.46%
+74%-15%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CTEV versus RPAY key metrics
MetricCTEVRPAY
Share price$18.28$3.83
Market cap$312.13M$363.92M
1-day change-3.94%-4.49%
YTD return-57.24%+4.93%
1-year return-61.21%+21.20%
5-year return-89.49%-77.62%
Forward P/E2.383.88
EPS (TTM)$-16.41$-2.02
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$965.41M$309.26M
Revenue growth (YoY)+3.74%-1.21%
Net income (latest FY)$-284.28M$-256.72M
Gross margin73.75%75.02%
Operating margin2.98%-82.36%
Net margin-29.45%-83.01%
52-week high$55.50$4.81
52-week low$11.50$2.30
Distance from 52-week high-67.06%-20.29%
Analyst consensusbuybuy
Avg. price target upside+165.86%+68.67%
Average volume210.93K439.34K
Shares outstanding17.07M89.73M
Employees3,000486
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RPAY has outperformed CTEV by 82.4 percentage points over the past year.
  • Claritev is more profitable, keeping -29.4 cents of every revenue dollar as net income versus -83.0 cents for Repay.

About Claritev

CTEV stock →

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services.

Consumer Discretionary · Business Services · 3,000 employees

About Repay

RPAY stock →

Repay Holdings Corporation, a payments technology company, provides integrated payment processing solutions that enables consumers and businesses to make payments using electronic payment methods in the United States. It operates through two segments: Consumer Payments and Business Payments.

Consumer Discretionary · Business Services · 486 employees

CTEV vs RPAY FAQ

Which is bigger, Claritev or Repay?

Repay (RPAY) is larger, with a market capitalization of $363.92M compared with $312.13M for Claritev (CTEV).

Which stock has performed better over the past year, CTEV or RPAY?

RPAY returned +21.20% over the past 12 months, compared with -61.21% for CTEV (price return, excluding dividends). Past performance does not predict future results.

Are Claritev and Repay in the same industry?

Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.

More comparisons